AdvanCell Announces $18M MRFF Funding for Prostate Cancer Therapy
AdvanCell, a clinical-stage radiopharmaceutical company developing innovative cancer therapeutics, today announced $18M in Australian Federal Government Funding from the Medical Research Future Fund (MRFF) Frontiers...